financetom
Business
financetom
/
Business
/
Perrigo Q4 Adjusted Earnings Increase, Sales Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Perrigo Q4 Adjusted Earnings Increase, Sales Decline
Feb 27, 2025 2:59 PM

05:41 PM EST, 02/27/2025 (MT Newswires) -- Perrigo ( PRGO ) reported Q4 adjusted earnings late Thursday of $0.93 per diluted share, up from $0.86 a year earlier.

Analysts polled by FactSet expected $0.92.

Net sales for the quarter that ended Dec. 31 were $1.14 billion, down from $1.16 billion a year earlier.

Analysts surveyed by FactSet expected $1.19 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stellus Capital Investment Insider Bought Shares Worth $318,865, According to a Recent SEC Filing
Stellus Capital Investment Insider Bought Shares Worth $318,865, According to a Recent SEC Filing
Mar 17, 2026
05:14 PM EDT, 03/17/2026 (MT Newswires) -- Robert T. Ladd, Director, President, and CEO, on March 13, 2026, executed a purchase for 36,700 shares in Stellus Capital Investment ( SCM ) for $318,865. Following the Form 4 filing with the SEC, Ladd has control over a total of 669,635 common shares of the company, with 669,635 shares held directly. SEC...
Rocket Lab Stock Surges 10%, Then Drops On $1 Billion Offering
Rocket Lab Stock Surges 10%, Then Drops On $1 Billion Offering
Mar 17, 2026
Rocket Lab Corp ( RKLB ) shares are moving lower in Tuesday’s after-hours session after the company filed for a potential offering of up to $1 billion. Rocket Lab ( RKLB ) stock is showing notable weakness. What’s weighing on RKLB shares? Rocket Lab Files For Offering After the market close on Tuesday, Rocket Lab ( RKLB ) announced it had...
Lantheus Says US FDA Pushes Back Review of Diagnostic Imaging Kit
Lantheus Says US FDA Pushes Back Review of Diagnostic Imaging Kit
Mar 17, 2026
05:11 PM EDT, 03/17/2026 (MT Newswires) -- Lantheus ( LNTH ) said Tuesday that the US Food and Drug Administration has delayed its decision on LNTH-2501 by three months to June 29 to evaluate additional manufacturing information. LNTH-2501 is a diagnostic kit for use with positron emission tomography, or PET, imaging to identify neuroendocrine tumors, a type of cancer. The...
Brazil to negotiate soybean inspection framework after Chinese complaints, minister says
Brazil to negotiate soybean inspection framework after Chinese complaints, minister says
Mar 17, 2026
* Brazil denies reports of eased soybean inspection rules * Officials to propose sanitary protocol in China next week * Traders complain tighter checks slow shipments, raise costs during peak season By Gabriel Araujo SAO PAULO, March 17 (Reuters) - Brazilian Agriculture Minister Carlos Favaro said on Tuesday that the government will negotiate soybean inspection and safety requirements for Brazilian...
Copyright 2023-2026 - www.financetom.com All Rights Reserved